Cargando…

Patient-reported outcomes of ocriplasmin for the treatment of vitreomacular traction: a systematic review and synthesis of the literature

PURPOSE: Vitreomacular traction (VMT) is a disease in which the vitreous exerts abnormally strong traction on the macula, the area of the eye responsible for detailed central vision. If this traction significantly distorts the macula then VMT can lead to troublesome distorted vision (metamorphopsia)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lescrauwaet, Benedicte, Blot, Koenraad, Jackson, Timothy L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443223/ https://www.ncbi.nlm.nih.gov/pubmed/30988647 http://dx.doi.org/10.2147/PROM.S153718

Ejemplares similares

Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole
por: Bennison, Craig, et al.
Publicado: (2016)

Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole
por: Jackson, Timothy L., et al.
Publicado: (2017)

Ocriplasmin for Treatment of Vitreomacular Traction: An Update
por: Khan, Mohammed Ali, et al.
Publicado: (2016)

Incomplete Vitreomacular Traction Release Using Intravitreal Ocriplasmin
por: Chin, Eric K., et al.
Publicado: (2014)

OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT Study
por: Steel, David H. W., et al.
Publicado: (2020)

Effectiveness of ocriplasmin in real‐world settings: A systematic literature review, meta‐analysis, and comparison with randomized trials
por: Khanani, Arshad M., et al.
Publicado: (2020)

Recurrent Vitreomacular Traction in a Patient Treated with Ocriplasmin: A Case Report
por: Katsanos, Andreas, et al.
Publicado: (2020)

Functional improvement assessed by multifocal electroretinogram after Ocriplasmin treatment for vitreomacular traction
por: Rossi, Settimio, et al.
Publicado: (2016)

Vitreomacular traction quantitative cutoffs for the assessment of resolution after ocriplasmin intravitreal treatment
por: Arrigo, Alessandro, et al.
Publicado: (2020)

Comparison of Guided and Unguided Ocriplasmin Injection for the Treatment of Vitreomacular Traction: A Preliminary Study
por: Mastropasqua, Rodolfo, et al.
Publicado: (2016)

Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin
por: DaCosta, Joanna, et al.
Publicado: (2014)

Ocriplasmin in the Treatment of Vitreomacular Traction in a Patient with Central Retinal Vein Occlusion: A Case Report
por: Rosati, Alessandra, et al.
Publicado: (2018)

Effect of Funding Source on “Spin” in Studies of Ocriplasmin Therapy for Vitreomacular Traction and Macular Hole
por: Hubschman, Sasha, et al.
Publicado: (2020)

Visual functional changes after ocriplasmin injection for vitreomacular traction: A microperimetric analysis
por: Furino, Claudio, et al.
Publicado: (2020)

Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion
por: Stefanini, Francisco R, et al.
Publicado: (2014)

Intravitreal ocriplasmin for the treatment of vitreomacular traction and macular hole- A study of efficacy and safety based on NICE guidance
por: Muqit, Mahiul M. K., et al.
Publicado: (2018)

ASSESSMENT OF ANATOMICAL AND FUNCTIONAL OUTCOMES WITH OCRIPLASMIN TREATMENT IN PATIENTS WITH VITREOMACULAR TRACTION WITH OR WITHOUT MACULAR HOLES: Results of OVIID-1 Trial
por: Tadayoni, Ramin, et al.
Publicado: (2019)

Calculating the individual probability of successful ocriplasmin treatment in eyes with vitreomacular traction–Validation and refinement of a multivariable prediction model
por: Paul, Christoph, et al.
Publicado: (2022)

Reduced perfusion density of superficial retinal capillary plexus after intravitreal ocriplasmin injection for idiopathic vitreomacular traction
por: Iuliano, Lorenzo, et al.
Publicado: (2019)

Patient-reported prevalence of metamorphopsia and predictors of vision-related quality of life in vitreomacular traction: a prospective, multi-centre study
por: Patel, Praveen J., et al.
Publicado: (2018)

Ocriplasmin for symptomatic vitreomacular adhesion: an evidence-based review of its potential
por: Song, Su Jeong, et al.
Publicado: (2014)

Predicting the individual probability of macular hole closure following intravitreal ocriplasmin injections for vitreomacular traction release using baseline characteristics
por: Bertelmann, Thomas, et al.
Publicado: (2021)

Early vitreomacular separation with delayed macular hole closure after ocriplasmin treatment
por: Liang, I-Chia, et al.
Publicado: (2016)

Vitreomacular Traction Syndrome
por: Bottós, Juliana, et al.
Publicado: (2012)

Vitreomacular traction syndrome
por: Martins, Thiago Gonçalves dos Santos, et al.
Publicado: (2015)

Vitreomacular traction associated with papillitis
por: Haq, Zeeshan, et al.
Publicado: (2020)

Pneumatic Vitreolysis for the Treatment of Vitreomacular Traction Syndrome
por: Özdemir, Hüseyin Baran, et al.
Publicado: (2019)

Incidence and prevalence of vitreomacular traction with and without macular hole in Germany
por: Menzler, Jacob, et al.
Publicado: (2019)

Efficacy and Safety of Ocriplasmin Use for Vitreomacular Adhesion and Its Predictive Factors: A Systematic Review and Meta-Analysis
por: Chen, Xi, et al.
Publicado: (2022)

Surgical Outcome of Vitreomacular Traction Associated With Macular Hole
por: Tayyab, Mashal, et al.
Publicado: (2022)

PNEUMATIC VITREOLYSIS FOR RELIEF OF VITREOMACULAR TRACTION
por: Chan, Clement K., et al.
Publicado: (2017)

Vitreomacular traction release: Finding the edge
por: Shah, Dhaivat
Publicado: (2022)

PATIENT-REPORTED VISUAL FUNCTION FROM THE OCRIPLASMIN FOR TREATMENT FOR SYMPTOMATIC VITREOMACULAR ADHESION, INCLUDING MACULAR HOLE (OASIS) STUDY
por: Mein, Calvin, et al.
Publicado: (2020)

Vitreomacular Interface: From Anterior to Tangential Traction
por: Romano, Mario R., et al.
Publicado: (2015)

Vitreomacular Traction and Outer Retinal Structural Changes
por: Yıldırım, Şeyda, et al.
Publicado: (2019)

Factors Associated with the Clinical Course of Vitreomacular Traction
por: Petrou, Petros, et al.
Publicado: (2020)

Partial-thickness macular hole in vitreomacular traction syndrome: a case report and review of the literature
por: Kumar, Niranjan, et al.
Publicado: (2010)

A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial
por: Blot, Koenraad, et al.
Publicado: (2019)

OCT-guided Hyaloid Release for Vitreomacular Traction Syndrome
por: Chung, Eun Jee, et al.
Publicado: (2008)

Redesigning services for the management of vitreomacular traction and macular hole
por: Amoaku, W, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d825t1hqplncubplnd04kjj73a